Table 2. Clinicopathological data of patients with Metastasis V.
| Patients | Age/ gender | Tumor size(cm) | Tumor location | Metastasis V location | Histological grade | Depth of Invasion | Lymph node metastasis | TNM Staging |
|---|---|---|---|---|---|---|---|---|
| 1 | 44/Female | 2.0 | Lower | mRGEV | Por | Serosal | Positive(7/26) | T3N3M0 |
| 2 | 34/Female | 3.0 | Upper | mLGV | Por | Serosal | Positive(1/21) | T3N1M0 |
| 3 | 54/Male | 3.0 | Upper | mLGV | Por | Serosal | Positive(4/22) | T3N1M0 |
| 4 | 54/Male | 5.0 | Lower | mRGEV | Mod | Submucosa | Positive(8/30) | T1bN3M0 |
| 5 | 61/Male | 2.0 | Lower | mLGV, mRGV | Mod | Serosal | Positive(3/34) | T3N2M0 |
| 6 | 66/Male | 5.0 | Middle | mLGV | Por | Serosal | Positive(2/29) | T4aN1M0 |
| 7 | 69/Male | 1.5 | Middle | mLGV | Por | Serosal | Positive(2/13) | T4aN1M0 |
| 8 | 38/Female | 3.0 | Lower | mRGEV | Mod | Serosal | Positive(22/32) | T3N3M0 |
| 9 | 71/Male | 3.0 | Lower | mRGEV | Mod | Subserosal | Negative(0/28) | T3N0M0 |
Por: poorly differentiated adenocarcinoma, Mod: moderately differentiated adenocarcinoma.